To report the neuro-ophthalmological findings in the TAFRO syndrome in a South American patient.
This is a case report of a patient with TAFRO syndrome.
We present the case of a 66-year-old woman with TAFRO syndrome and multicentric Castleman disease, who developed ophthalmic manifestations, as a rare complication, including optic disk edema and serous retinal detachment, which improved with conventional therapy.
The optic disk edema could be present as a neuro-ophthalmological finding in TAFRO syndrome. To the best of our knowledge, this is the first report on the ophthalmic manifestations in the TAFRO syndrome.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Takai K, Nikkuni K, Shibuya H, Hashidate H (2010) Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki 51(5):320–325
Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y et al (2016) Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol 103(6):686–692
Yasuda S, Tanaka K, Ichikawa A, Watanabe K, Uchida E, Yamamoto M et al (2016) Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy. Int J Hematol 104(4):512–518
Simons M, Apor E, Butera JN, Treaba DO (2016) TAFRO syndrome associated with EBV and successful triple therapy treatment: case report and review of the literature. Case Rep Hematol 2016:4703608
Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S et al (2013) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop 53(1):57–61
Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A et al (2015) Successful treatment of a Caucasian case of multifocal Castleman’s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol 4(1):3
Abdo LA, Morin CP, Collarino RP, Cabane JP, Gatfosse MA (2014) First European case of TAFRO syndrome associated with Sjogren disease. Am J Intern Med 2(6):102–105
Contardo D, Finocchietto P, Uehara T, Papini C, Deligiannis N, Darderes E et al (2015) TAFRO syndrome in a patient of south-american descent. EJCRIM. doi:10.12890/2015_000220
Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 9(4):822–830
Allegra A, Rotondo F, Russo S, Calabrò L, Maisano V, Bacci F et al (2015) Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: a rare case report and review of the literature. Blood Cells Mol Dis 55(3):206–207
Takasawa N, Sekiguchi Y, Takahashi T, Muryoi A, Satoh J, Sasaki T (2016) A case of TAFRO syndrome, a variant of multicentric Castleman’s disease, successfully treated with corticosteroid and cyclosporine A. Mod Rheumatol 14:1–5
Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M et al (2016) Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 91(2):220–226
Kumar S, Sharma S (2015) Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS syndrome): a paraneoplastic syndrome. Oxf Med Case Rep 3:237–240
Carbone A, Pantanowitz L (2016) TAFRO syndrome: an atypical variant of KSHV-negative multicentric Castleman disease. Am J Hematol 91(2):171–172
Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T et al (2013) Japanese variant of multicentric Castleman’s disease associated with serositis and thrombocytopenia—a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop 53(1):79–85
Kawashima M, Usui T, Okada H, Mori I, Yamauchi M, Ikeda T et al (2015) TAFRO syndrome: 2 cases and review of the literature. Mod Rheumatol 20:1–5
Kojima M, Nakamura N, Otuski Y, Itoh H, Ogawa Y, Kobayashi H et al (2008) Pulmonary lesion of idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia appears to be a cause of lymphoplasmacytic proliferation of the lung: a report of five cases. Pathol Res Pract 204(3):185–190
Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Ueda Y (2016) TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review. Mod Rheumatol 17:1–6
Kourelis TV, Buadi FK, Kumar SK, Gertz MA, Lacy MQ, Dingli D et al (2016) Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience. Am J Hematol 91(6):585–589
All the scientific and ethical principles of the Helsinki Declaration on Human Research were respected.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Conflict of interest
The authors declare that there is no conflict of interest.
All the sources were provided by the authors.
About this article
Cite this article
Ortiz, A., Cárdenas, P., Peralta, M. et al. Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman’s disease. Int Ophthalmol 38, 1641–1646 (2018). https://doi.org/10.1007/s10792-017-0636-x
- Optic nerve disease
- Multicentric Castleman’s disease